Ceribell director William Burke sells $479,479 in stock

William W. Burke, a director at Ceribell Inc., divested 18,000 shares of the company's stock on November 12, 2026, generating roughly $479,479. The shares were exchanged at prices oscillating between $26.58 and $27.48, as part of a previously established Rule 10b5-1 trading strategy. This action occurred following a remarkable 103% increase in the stock's value over the past year; however, analysis by InvestingPro indicates the stock is presently overvalued in relation to its intrinsic value.

To gain further insights, readers may access up to ten ProTips and a full Pro Research Report, exclusively available through InvestingPro. The transactions included 16,845 shares, exchanged at an average price of $26.58 per share ($26.30 to $26.99 individually), and 1,155 shares, sold at $27.48 per share ($27.34 to $27.72 individually).

Prior to these sales, Burke had acquired 18,000 shares of Ceribell common stock via the exercise of a stock option, which was fully vested at a price of $4.70 per share, totaling $84,600. This constituted a total holding of 23,022 shares of Ceribell (NASDAQ:CBLL) common stock post-deal. Recently, Ceribell disclosed its Q3 2026 revenue, which climbed to $29.3 million, reflecting a 30% increase from the prior year.

Nevertheless, the company reported a loss of $0.55 per share, which exceeded market expectations of a $0.34 loss. BTIG retained a Buy rating on Ceribell, targeting a price of $30.00 following these financial results. The firm's product revenue amounted to $22.2 million, marginally above the consensus estimate of $22.0 million, while subscription revenue was $7.1 million, slightly lower than the anticipated $7.2 million.

These financial outcomes suggest Ceribell experienced robust revenue growth but encountered difficulties in meeting earnings projections. This report was produced utilizing AI assistance and subsequently reviewed by an editor. For additional details, visit our Terms and Conditions.